|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| C12N 15/864 | |||
| C12N 9/64 |
| (11) | Number of the document | 2438931 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12150318.9 |
| Date of filing the European patent application | 2005-09-09 | |
| (97) | Date of publication of the European application | 2012-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 612135 P | 2004-09-22 | US |
| (72) |
Gray, John Trainor, US
|
| (73) |
St. Jude Children`s Research Hospital,
262 Danny Thomas Place, Memphis, Tennessee 38105,
US
|
| (54) | Improved expression of factor IX in gene therapy vectors |
| Improved expression of factor IX in gene therapy vectors |